Cardinal Health, McKesson, Georgia dominates opioid trials

Published Date: 08 Mar 2023

At a trial in Georgia on Wednesday, three drug traffickers won a case brought by the family of a drug addict, accusing the company of selling drugs.

Read Full News

Latest News

WHO Says Ebola Response Catching Up as Confirmed DRC Cases Hit 344

The World Health Organization said on Wednesday that the world is "catching up" with the Ebola outbreak in Democratic Republic of Congo, where there ⁠have been 344 confirmed...

Deep Dive: IL Inhibitor and JAK Inhibitor in Atopic Dermatitis

IL-4 and IL-13 drive the inflammation that breaks down the skin barrier and fuels the “atopic march” when atopic dermatitis (AD) progresses to other allergic diseases. Dupilumab blocks signaling through both pathways, delivering disease control that can persist even after treatment discontinuation in some patients.

US to Re-engage With Gavi Vaccine Alliance Amid Ebola Outbreak, Rubio Says

U.S. Secretary of State Marco Rubio said on Tuesday that the U.S. would re-engage with the global vaccine alliance Gavi amid the Ebola outbreak in several African...

Flesh-eating Screwworm Found Within 31 Miles of US Border, Says USDA

A devastating parasitic fly that eats warm-blooded animals alive and could cause millions of dollars in economic ⁠damage to the U.S. economy has been found in a young sheep...

Trump Signs Order to Use HHS Vaccine Assessment as Federal Guide

U.S. President Donald Trump signed an executive order to ⁠acknowledge a recent scientific assessment by the Department of Health and Human ⁠Services on childhood vaccines as...

US Regulator Approves Oral Drug From Japan's Shionogi to Prevent COVID-19

Japan's Shionogi & Co said on Monday ⁠the U.S. Food and Drug Administration has approved ⁠its oral antiviral Ensitrelvir, commercially known as ⁠Xocova, for the...

Todays Updates

Isatuximab Boosts MRD Negativity in Multiple Myeloma

Researchers compare two different treatment regimens in 446 transplant-ineligible patients with newly diagnosed multiple myeloma in a global phase 3 trial.

Novel ADC Improves Survival in Metastatic TNBC

Izalontamab brengitecan extends overall survival among patients with metastatic TNBC, but it’s unclear how the investigational therapy might fit into an evolving treatment landscape.

Proton Therapy Fails to Beat IMRT in Prostate Cancer

For men with localized prostate cancer, proton therapy looks no better than IMRT when it comes to 3-year biochemical progression or GI toxicity.

Fuzuloparib Add-On Improves Metastatic Prostate Cancer rPFS

Researchers track progression-free survival after adding a PARP inhibitor to a standard regimen for metastatic castration-resistant prostate cancer.

Todays Updates

Isatuximab Boosts MRD Negativity in Multiple Myeloma

Researchers compare two different treatment regimens in 446 transplant-ineligible patients with newly diagnosed multiple myeloma in a global phase 3 trial.

Novel ADC Improves Survival in Metastatic TNBC

Izalontamab brengitecan extends overall survival among patients with metastatic TNBC, but it’s unclear how the investigational therapy might fit into an evolving treatment landscape.

Proton Therapy Fails to Beat IMRT in Prostate Cancer

For men with localized prostate cancer, proton therapy looks no better than IMRT when it comes to 3-year biochemical progression or GI toxicity.

Fuzuloparib Add-On Improves Metastatic Prostate Cancer rPFS

Researchers track progression-free survival after adding a PARP inhibitor to a standard regimen for metastatic castration-resistant prostate cancer.

Latest News

The World Health Organization said on Wednesday that the world is "catching up" with the Ebola outbreak in Democratic Republic of Congo, where there ⁠have been 344 confirmed...

IL-4 and IL-13 drive the inflammation that breaks down the skin barrier and fuels the “atopic march” when atopic dermatitis (AD) progresses to other allergic diseases. Dupilumab blocks signaling through both pathways, delivering disease control that can persist even after treatment discontinuation in some patients.

U.S. Secretary of State Marco Rubio said on Tuesday that the U.S. would re-engage with the global vaccine alliance Gavi amid the Ebola outbreak in several African...

A devastating parasitic fly that eats warm-blooded animals alive and could cause millions of dollars in economic ⁠damage to the U.S. economy has been found in a young sheep...

U.S. President Donald Trump signed an executive order to ⁠acknowledge a recent scientific assessment by the Department of Health and Human ⁠Services on childhood vaccines as...

Japan's Shionogi & Co said on Monday ⁠the U.S. Food and Drug Administration has approved ⁠its oral antiviral Ensitrelvir, commercially known as ⁠Xocova, for the...

News All Time

Inside an African Lab That Helped Crack the Hantavirus Outbreak

(Clarifies status of Istitut Pasteur de Dakar in paragraphs 6, 8-9)

Chikungunya in Pregnancy Raises Infant Hospital Risk

A cohort study of births in Brazil found increased hospitalization risk through age 3 after maternal chikungunya; results inform global surveillance and vaccination strategies.

UK Commits $26.87 Million to Contain Ebola Outbreak in DRC

Britain has allocated up to 20 million pounds ($26.87 million) in ⁠new aid funding to help contain an Ebola outbreak in eastern ⁠Democratic Republic of the Congo, the UK's...

US Working With Small Biotech Firm on Experimental Ebola Treatment, HHS Official Says

U.S. officials are working with Mapp Biopharmaceutical to make an experimental Ebola treatment available for people who may have been exposed to ⁠the virus, an HHS official...

Congenital CMV Linked to Substantial Long-Term Health Issues

An analysis conducted in an integrated healthcare system provided insights into the long-term healthcare burden of cCMV infection.

Why the Test-Negative Design Is Our Most Vital Tool for Vaccine Effectiveness

Dr Daskalakis explains vaccine study designs and how the science of test negative design, a decades-old, tried and true design, is now being called into question.

Test Shortages Slow Fight Against Ebola in Congo, WHO Official Says

Six tons of medical supplies to fight Ebola are set to arrive in the Democratic Republic of Congo on Tuesday, ⁠but limited testing capacity was slowing the response to the...

Bird Flu Found in Polar Bear in Europe for First Time

Bird flu has been detected in a dead polar bear in the ⁠Arctic Svalbard archipelago, the first time the virus has been found in the species in ⁠Europe.

US States Reject Anti-vaccine Bills as Public Health Groups Fight MAHA

Dozens of state anti-vaccine bills backed by "Make America Healthy Again" supporters have failed after public health groups won over Republican state lawmakers, marking a...

US Health Department Withdraws Vaccine Advisory Panel Charter

The U.S. health department has withdrawn an April charter renewal for a key vaccine ⁠advisory panel that laid out new membership rules and direction, citing an...

Adult Dies of Hantavirus in Colorado, State Health Officials Say

An adult in Colorado has died after a confirmed ⁠case of hantavirus that is not linked to a recent outbreak aboard ⁠a cruise ship in the Atlantic, Colorado Department of...

Britain Gets Experimental Drug From Japan to Bolster Hantavirus Response

Britain has received supplies of the antiviral drug favipiravir from Japan as part of its response to a deadly hantavirus ⁠outbreak linked to the Hondius cruise liner, the...

Rapid Tests: What We Gain in Speed, We Risk in Certainty

Dr Alok Patel examines the trade-offs behind rapid testing, from diagnostic accuracy and patient behavior to cost, workflow, and clinical judgment.

FDA Drug Center Head Fired After Commissioner's Exit, Replaced by Davis

The acting head of the U.S. Food and Drug Administration's drug center, Tracy Beth Hoeg, was fired on Friday, according to her ⁠social media post, and has been replaced by...

Mexico Suspends Imports of Some US Pork Products Over Virus

Mexico has suspended imports from the U.S. of breeding pigs, semen, viscera and pork offal products after ⁠U.S. authorities detected pseudorabies virus antibodies in some...

U.S. Reports no Hantavirus Cases From Cruise Outbreak, Monitors 41

There are no confirmed cases in the United States of the Andes hantavirus outbreak that killed three people aboard ⁠a luxury cruise ship this month, U.S. health officials...

Recommended News For You

These Athletes Weren't Doping. Their Genes Made It Look Like They Did.

FDA Expands Approval of Osimertinib in Lung Cancer

Silibinin is a novel and ancient molecule that highlights the significance of integrated therapies for cancer.

3D virtual staining technology enables non-invasive observation of cancer tissue

CAR-T cell therapy for cancer causes 'brain fog,' study shows

Utilizing cerium/lanthanum-134 to improve cancer detection and treatment.

Fitness levels for the heart and lungs are linked to a lower mortality from cancer in men.

Recommended Articles For You

Hemophilia Beyond Boundaries: Unconventional Therapies in Bleeding Disorder Care 

Case Study: Advancing Preclinical Oncology Drug Development with Quantitative Systems Pharmacology 

Adjuvant Atezolizumab in TNBC: What Recent Trials Reveal About Its Role 

Understanding Hemosiderosis: Causes, Symptoms, and Treatment Options 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Can Oligonucleotide Infusions Really Fix Lyme, Cancer, and Other Diseases?

2.

The Risk of Major Mortality is Associated with the Start of Opioids in Dementia.

3.

Prostate cancer relapse after radiotherapy is strongly predicted by biological markers.

4.

Most women with early-stage breast cancer can anticipate living long lives, according to experts.

5.

Including Isatuximab with a Standard Backbone Enhances Multiple Myeloma Results.

1.

How to Prevent Tumor Lysis Syndrome in Cancer Patients

2.

Autophagy: A Double-Edged Sword in Cancer Development, Immune Evasion, and Drug Resistance

3.

Managing KRAS Inhibitor Toxicities: Focus on Rash and Beyond

4.

Understanding Waldenstrom Macroglobulinemia - A Comprehensive Guide 

5.

Revolutionizing Cancer Care: The Transformative Role of AI and Data Science in Oncology

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

International Lung Cancer Congress®

3.

Genito-Urinary Oncology Summit 2026

4.

Future NRG Oncology Meeting

5.

ISMB 2026 (Intelligent Systems for Molecular Biology)

1.

Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases

2.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI

3.

Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial

4.

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

5.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot